Background: The recurrence of hepatocellular carcinoma (HCC) is the strongest survival-limiting factor after liver transplantation (LT) in patients with HCC. In the face of donor organ shortage, it is necessary to identify factors associated with HCC recurrence in order to maximize the utility of the available grafts. Objective: To study the phenomenon of HCC recurrence after LT at a European transplantation centre over the past 20 years. Methods: Data from 304 HCC patients who underwent LT were prospectively recorded. Clinical and pathological factors were assessed for their association with recurrence. Results: Fifty-one patients (16.8%) had HCC recurrence after LT. Patients exceeding the Milan criteria developed HCC recurrence more frequently. The time point of recurrence did not affect survival after recurrence. Furthermore, there was no difference in survival between patients with intra- and extrahepatic recurrence. However, patients with recurrence due to needle tract seeding had a significantly better outcome than patients with other sites of recurrence. Conclusion: Our data support a restrictive use of patient selection criteria to help identify patients who have an increased risk of HCC recurrence after LT, and highlight the need to improve patient selection before LT in order to minimize the rate of HCC recurrence.
Background: The recurrence of hepatocellular carcinoma (HCC) is the strongest survival-limiting factor after liver transplantation (LT) in patients with HCC. In the face of donor organ shortage, it is necessary to identify factors associated with HCC recurrence in order to maximize the utility of the available grafts. Objective: To study the phenomenon of HCC recurrence after LT at a European transplantation centre over the past 20 years. Methods: Data from 304 HCC patients who underwent LT were prospectively recorded. Clinical and pathological factors were assessed for their association with recurrence. Results: Fifty-one patients (16.8%) had HCC recurrence after LT. Patients exceeding the Milan criteria developed HCC recurrence more frequently. The time point of recurrence did not affect survival after recurrence. Furthermore, there was no difference in survival between patients with intra- and extrahepatic recurrence. However, patients with recurrence due to needle tract seeding had a significantly better outcome than patients with other sites of recurrence. Conclusion: Our data support a restrictive use of patient selection criteria to help identify patients who have an increased risk of HCC recurrence after LT, and highlight the need to improve patient selection before LT in order to minimize the rate of HCC recurrence.
Authors: Vatche G Agopian; Michael P Harlander-Locke; Richard M Ruiz; Goran B Klintmalm; Srinath Senguttuvan; Sander S Florman; Brandy Haydel; Maarouf Hoteit; Matthew H Levine; David D Lee; C Burcin Taner; Elizabeth C Verna; Karim J Halazun; Rita Abdelmessih; Amit D Tevar; Abhinav Humar; Federico Aucejo; William C Chapman; Neeta Vachharajani; Mindie H Nguyen; Marc L Melcher; Trevor L Nydam; Constance Mobley; R Mark Ghobrial; Beth Amundsen; James F Markmann; Alan N Langnas; Carol A Carney; Jennifer Berumen; Alan W Hemming; Debra L Sudan; Johnny C Hong; Joohyun Kim; Michael A Zimmerman; Abbas Rana; Michael L Kueht; Christopher M Jones; Thomas M Fishbein; Ronald W Busuttil Journal: Ann Surg Date: 2017-09 Impact factor: 12.969
Authors: Gerd Otto; Marcus Schuchmann; Maria Hoppe-Lotichius; Michael Heise; Arndt Weinmann; Torsten Hansen; Michael P Pitton Journal: J Hepatol Date: 2013-04-12 Impact factor: 25.083
Authors: Michael A Zimmerman; R Mark Ghobrial; Myron J Tong; Jonathan R Hiatt; Andrew M Cameron; Johnny Hong; Ronald W Busuttil Journal: Arch Surg Date: 2008-02
Authors: Karim J Halazun; Marc Najjar; Rita M Abdelmessih; Benjamin Samstein; Adam D Griesemer; James V Guarrera; Tomoaki Kato; Elizabeth C Verna; Jean C Emond; Robert S Brown Journal: Ann Surg Date: 2017-03 Impact factor: 12.969
Authors: Vincenzo Mazzaferro; Carlo Sposito; Jian Zhou; Antonio D Pinna; Luciano De Carlis; Jia Fan; Matteo Cescon; Stefano Di Sandro; He Yi-Feng; Andrea Lauterio; Marco Bongini; Alessandro Cucchetti Journal: Gastroenterology Date: 2017-10-05 Impact factor: 22.682
Authors: V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari Journal: N Engl J Med Date: 1996-03-14 Impact factor: 176.079
Authors: Christine Koch; Theresa Bette; Oliver Waidmann; Natalie Filmann; Christopher Schrecker; Jörg Trojan; Nina Weiler; Johannes Vermehren; Andreas A Schnitzbauer; Wolf Otto Bechstein; Stefan Zeuzem; Eva Herrmann; Martin-Walter Welker Journal: PLoS One Date: 2020-07-02 Impact factor: 3.240